PMID: 6168360Aug 15, 1981Paper

VAB-3 combination chemotherapy of metastatic testicular cancer

Cancer
T F ReynoldsR Golbey

Abstract

The initial response and long-term follow-up of 74 evaluable patients who received combination chemotherapy for metastatic nonseminomatous testicular cancer are reported. Patients were treated with a protocol (VAB-3) including vinblastine, actinomycin-D, bleomycin, and cis-dichlorodiammine platinum (DDP). VAB-3 alone caused complete remission (CR) in 54% (40/74) and partial remission (PR) in 26% (1974). Five patients with less than CR to chemotherapy achieved CR following surgical excision of residual mature teratoma after starting VAB-3 protocol, resulting in an overall CR rate of 61% (45/74). With a minimum follow-up of 24+ months, and a median follow-up of 35+ months for those still living, 45% (33/74) of the patients are living free of evidence of disease, 4% (3/74) are living with disease, and 51% (38/74) are dead. Response to VAB-3 protocol was examined with respect to performance status, histology, prior therapy, extent of disease, tumor markers, and duration of disease from diagnosis. No one died because of toxicity of VAB-3, and life-threatening toxicity was uncommon. Long survival is significantly associated (P less than 0.001) with achievement of CR. The treatment goal for metastatic testicular cancer is cure. The ac...Continue Reading

References

Dec 1, 1976·Cancer Treatment Reviews·M L SamuelsD E Johnson
Nov 1, 1969·Lancet·D W Smithers
Mar 1, 1973·American Journal of Clinical Pathology·G W Willis, S I Hajdu
Aug 1, 1972·The Journal of Urology·S MonfardiniG Bonadonna
Sep 1, 1969·Cancer·F J AnsfieldG Ramirez
Nov 5, 1960·JAMA : the Journal of the American Medical Association·M C LIH GRABSTALD

❮ Previous
Next ❯

Citations

Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S CulineJ P Droz
Apr 1, 1996·Critical Reviews in Oncology/hematology·S CulineJ P Droz
Apr 26, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu Miki, Masahiro Nakao
Aug 1, 1984·Australasian Radiology·K W Tiver, A O Langlands
Jan 1, 1985·Acta Radiologica. Oncology·O Dahl
Nov 1, 1983·The American Journal of Medicine·J D Hainsworth, F A Greco
Jun 1, 1984·European Journal of Cancer & Clinical Oncology·A J SuurmeijerG J Fleuren
May 1, 1986·European Journal of Cancer & Clinical Oncology·S W HansenM Rørth
Jan 1, 1982·Medical and Pediatric Oncology·R B Raney
May 9, 2007·The Urologic Clinics of North America·G Varuni Kondagunta, Robert J Motzer
Feb 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K AraiH Suzuki
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madhu MazumdarGeorge J Bosl
Mar 15, 1987·Cancer·R B RaneyP Littman
Jun 25, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A FuntGeorge J Bosl
Sep 1, 1983·The Journal of Urology·J J BredaelW F Whitmore
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M T MeinardiD T Sleijfer
Sep 22, 1998·Current Problems in Cancer·C R Nichols

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.